GLENMEDE TRUST CO NA
BankPosition in HALO — Halozyme Therapeutics, Inc.
CIK 314949
PHILADELPHIA, PA
Position in HALO
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$11,060,881
+$1,578,562 QoQ
Shares Held
141,317
-3.7% QoQ
Ownership
0.125%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#112
of 664 holders
Holding Since
Jun 2020
18 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GLENMEDE TRUST CO NA holds $148,775,467 across 46 Biotechnology names. HALO ranks #4 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
538,822 | $61,080,861 | |
| 2 | ACAD |
Acadia Pharmaceuticals Inc
|
488,546 | $12,360,212 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
206,405 | $11,810,493 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
This page
|
141,317 | $11,060,881 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
17,621 | $10,987,396 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12,722 | $6,319,398 | |
| 7 | VCEL |
Vericel Corp
|
139,921 | $6,225,084 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
7,637 | $2,413,979 |
All Filings in HALO
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,060,881 | 141,317 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $9,482,319 | 146,717 | Shares | Sole | 2026-05-26 | |
| 2025-12-31 | $8,066,981 | 119,866 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $31,843,039 | 499,029 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $23,137,744 | 483,952 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $27,883,377 | 487,131 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $19,784,120 | 377,848 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $15,139,711 | 372,166 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $12,371,214 | 334,719 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $13,109,781 | 343,188 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $12,496,667 | 346,456 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $13,205,986 | 345,797 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $19,471,179 | 342,200 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $15,207,042 | 384,599 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $18,972,140 | 431,185 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $19,079,707 | 478,428 | Shares | Sole | 2022-05-16 | |
| 2020-09-30 | $6,333 | 241 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,994 | 149 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||